0      0


Challenges and Opportunities in the Manufacturing of New Treatment Modalities


Jun 1, 2020 9:00am ‐ Jun 1, 2020 10:30am


Credits: None available.

Speaker(s):

  • Wilson Bryan, MD, Director, Office of Tissues and Advanced Therapies, FDA/CBER, CBER/FDA
  • Joseph Famulare, Conference Chair, VP Global Compliance & External Collaboration, Genentech, A Member of the Roche Group
  • Eric Felz, Associate Director Validation, Takeda Pharmaceutical Company
  • Tim Howard, PE, CPIP, Interim CEO & President, ISPE
  • Carol Lynch, President, Head-North America, Sandoz US

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content